Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
The Lancet. Oncology|December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialThomas Yau, Joong-Won Park, Richard S Finn, et al.
BMC Infectious Diseases|April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohortAnne Laurain, Sophie Metivier, Georges Haour, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitisJean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|July 13, 2020
Intestinal Virome in Patients With Alcoholic HepatitisLu Jiang, Sonja Lang, Yi Duan, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Journal of Hepatology|April 15, 2018
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitisKatharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
Alcohol (Fayetteville, N.Y.)|December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosisJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Cell Host & Microbe|May 29, 2025
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver diseaseYongqiang Yang, Yi Duan, Sonja Lang, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Nature Reviews. Gastroenterology & Hepatology|September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver diseaseLuis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
The Lancet. Oncology|December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialThomas Yau, Joong-Won Park, Richard S Finn, et al.
BMC Infectious Diseases|April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohortAnne Laurain, Sophie Metivier, Georges Haour, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitisJean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|July 13, 2020
Intestinal Virome in Patients With Alcoholic HepatitisLu Jiang, Sonja Lang, Yi Duan, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Journal of Hepatology|April 15, 2018
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitisKatharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
Alcohol (Fayetteville, N.Y.)|December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosisJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Cell Host & Microbe|May 29, 2025
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver diseaseYongqiang Yang, Yi Duan, Sonja Lang, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Nature Reviews. Gastroenterology & Hepatology|September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver diseaseLuis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Pageof 29